A retrospective analysis has been performed of the results of external beam radiotherapy for retinoblastoma using a whole eye technique. Local tumour control has been assessed in a consecutive series of 175 eyes in 142 children all of whom received external beam radiotherapy as the primary treatment for retinoblastoma. Follow up ranged from 2 to 17 years (median 9 years). Tumour control rates have been analysed with respect to the Reese Ellsworth classification and the series includes eyes in groups I to V. Focal salvage therapy was given for persistent, recurrent, or new tumours after radiotherapy. Following whole eye radiotherapy alone, the overall ocular cure rate was 57%, though with salvage therapy 80% of eyes could be preserved.
Retinoblastoma is a rare ocular neoplasm which accounts for only 30/o of childhood cancer. Although enucleation remains the standard treatment for advanced unilateral retinoblastoma and for the worse eye in most bilateral cases, many eyes can now be preserved by conservative therapy. The methods employed include external beam radiotherapy, radiation brachytherapy using episcleral radioactive plaques, cryotherapy, and photocoagulation. Using various combinations of these conservative treatment methods, overall local tumour cure rates for the eye have ranged between 80% and 900/o depending on the extent of tumour involvement. [1] [2] [3] [4] [5] Until 1985 the whole eye was usually irradiated in Britain.2 6 Since 1986 a reliable and reproducible lens sparing technique has become available which allows the whole retina to be treated without producing anterior segment side effects which include lagophthalmos, dry eye, and cataract.7-9 The results of whole eye external beam radiotherapy have been analysed in order to make objective comparisons with those of the newer lens sparing technique and, in particular, to establish that it is safe to spare the anterior segment. A noncurrent series of patients treated by the whole eye technique up to 1985 has been chosen to eliminate bias of selection because all suitable tumours after that date received the lens sparing approach. Possible doubts about the tumour control status of retinoblastomas which had received other forms of treatment before radiotherapy have been eliminated by considering only those eyes for which irradiation was the primary treatment. ..- Figure 3 Initial results of whole eye external beam radiotherapy. lesions arose anterior to the equator. In those eyes in which treatment failure and/or new tumour development occurred following primary whole eye radiotherapy, 78% were within the first year and 95% within the first 2 years after radiotherapy. The end point of the present study is preservation of the eye.
Following whole eye external beam radiotherapy, local tumour control was achieved in most but not in all eyes. There were several possible reasons for failure to achieve or sustain local tumour control. True failure occurred when one or more tumours failed to regress following treatment or when apparently regressed tumours subsequently recurred. In some eyes the treated tumours were controlled but new lesions developed. These were not strictly failures but were classified as such for the purposes of this study. Similarly, eyes lost from side effects were classified as failures. Most retinoblastomas which appear inert 9 months after external beam radiotherapy are probably cured4 and the 2 year minimum follow up interval ensures complete or near complete ascertainment of failures.
The fractionation schedules of external beam radiotherapy changed substantially during the period of the study. Although the total dose increased with greater fractionation, the nominal standard dose formula was applied and the three dose prescriptions are equivalent in terms of their ability to kill tumour cells. Nevertheless, the fractionation of many of the early treatments in this series would now be regarded as suboptimal from the point of view of side effects: three eyes were lost from side effects attributable to insufficient fractionation.
There are no strictly comparable earlier studies of whole eye external beam radiotherapy.13 Two large series have been reported but the treatment methods, follow up intervals, and the criteria by which a local cure is determined differ in each3 5 and in the present study. However, most eyes in both earlier series were treated initially by megavoltage external beam radiotherapy and subsequently by focal methods where necessary. Allowing for the differences outlined, the overall results of treatment in the three groups of patients summarised in Table 3 Overall, 80% of eyes in Reese-Ellsworth groups I to V were preserved by whole eye external beam radiotherapy either alone or in combination with salvage treatment. When comparing the results of lens sparing radiotherapy with those of the whole eye technique in terms of preserving the eye, it is important to recognise that the strict selection criteria applied when sparing the anterior segment, limit the use of the newer method mainly to eyes in Reese-Ellsworth groups I to III. The eye preservation rate for groups I to III after whole eye radiotherapy with or without salvage was 85% and it is this value which sets the standard by which the lens and anterior segment sparing technique must be judged.
